Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression-Reference-Cited by-同舟云学术

Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression

Published:2022-12-26 Issue:2 Volume:25 Page:99-109
ISSN:1398-5647
Container-title:Bipolar Disorders
language:en
Short-container-title:Bipolar Disorders

Author:

Fancy Farhan¹²^ORCID,Rodrigues Nelson B.¹,Di Vincenzo Joshua D.¹,Chau Edmond H.³,Sethi Rickinder¹⁴,Husain Muhammad I.⁴⁵^ORCID,Gill Hartej¹²^ORCID,Tabassum Aniqa¹,Mckenzie Andrea¹,Phan Lee¹,McIntyre Roger S.¹²³⁴⁶^ORCID,Rosenblat Joshua D.¹²³⁴⁶

Affiliation:

1. Mood Disorders Psychopharmacology Unit University Health Network Toronto Ontario Canada

2. Institute of Medical Science University of Toronto Toronto Ontario Canada

3. Braxia Scientific, Braxia Health, Canadian Rapid Treatment Centre of Excellence Mississauga Ontario Canada

4. Department of Psychiatry University of Toronto Toronto Ontario Canada

5. Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health Toronto Ontario Canada

6. Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bdi.13284

Reference56 articles.

1. Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

2. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

3. Antidepressant effects of ketamine in depressed patients

4. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

5. The use of ketamine as an antidepressant: a systematic review and meta-analysis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine and Esketamine for Depression in Daily Practice;Journal of Clinical Psychopharmacology;2024-08-22

2. Polish standard of treatment with racemic ketamine for patients with depressive disorders developed by a Working Group appointed by the National Consultant in the field of psychiatry;Psychiatria Polska;2024-06-30

3. Role of Electroconvulsive Therapy, Ketamine Infusion, and Deep Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression: A Case Report;Medicina;2024-06-03

4. Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders;Expert Opinion on Therapeutic Targets;2024-05-03

5. Fabrication of a Controlled-Release Core-Shell Floating Tablet of Ketamine Hydrochloride Using a 3D Printing Technique for Management of Refractory Depressions and Chronic Pain;Polymers;2024-03-08